These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 697397)

  • 1. [Effect of ethofibrate [2-(nicotinoyloxy)ethyl-p-chlorophenoxyisobutyrate] lipid metabolism. II. Effects on the incorporation of various isotopic precursors in rat liver].
    Priego JG; Maroto ML; Piña M; Catalán RE
    Arch Farmacol Toxicol; 1978 Apr; 4(1):28-30. PubMed ID: 697397
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of ethofibrate [2-(nicotinoyloxy)ethyl-p-chlorophenoxyisobutyrate] on lipid metabolism. I. Effect on blood lipids in normal and hyperlipemic rats].
    Maroto ML; Priego JG; Piña M; Catalán RE
    Arch Farmacol Toxicol; 1978 Apr; 4(1):25-7. PubMed ID: 697396
    [No Abstract]   [Full Text] [Related]  

  • 3. [Action of etofibrate, clofibrate and nicotinic acid on the metabolism of lipids in normolipemic rats. Short term effects and method of action].
    Priego JG; Piña M; Armijo M; Sunkel C; Maroto ML
    Arch Farmacol Toxicol; 1979 Apr; 5(1):29-42. PubMed ID: 38756
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of etofibrate, clofibrate and nicotinic acid on lipid metabolism in hyperlipidemic rats.
    Priego JG; Maroto ML; Piña M; Catalán RE
    Gen Pharmacol; 1979; 10(4):315-8. PubMed ID: 488666
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of etofibrate, clofibrate and nicotinic acid on lipid metabolism in normolipemic rats.
    Priego JG; Maroto ML; Piña M; Catalan RE
    Gen Pharmacol; 1979; 10(3):215-9. PubMed ID: 467961
    [No Abstract]   [Full Text] [Related]  

  • 6. [Lipid depression by etofibrate in a comparative study in rats with artificial hyperlipidemia].
    Sterner W; Schultz A
    Arzneimittelforschung; 1974 Dec; 24(12):1990-2. PubMed ID: 4480360
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mechanism of action of drugs affecting lipid metabolism].
    Rossini L
    Minerva Med; 1975 Oct; 66(66):3458-68. PubMed ID: 1178137
    [No Abstract]   [Full Text] [Related]  

  • 8. Stimulation of anti-aggregatory activity from rat aorta by hypolipidemic drugs.
    Weithmann KU; Granzer E
    Artery; 1980; 8(5):475-81. PubMed ID: 7011266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypolipaemic activity of 1-(theophyllin-7-yl)-ethyl-2-[2-(p-chlorophenoxy)-2-methylpropionate] (etofylline clofibrate) and its analogues in normolipaemic rats.
    Ginocchio AV; Metz G
    Arzneimittelforschung; 1980; 30(11b):2032-4. PubMed ID: 7194054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of orotic and nicotinic acids on the incorporation of 1-C14-acetate into the total lipids and cholesterol of rat liver].
    Chagovets RV; Shushevich SI; Khalmuradov AG
    Vopr Pitan; 1966; 25(2):24-9. PubMed ID: 5998316
    [No Abstract]   [Full Text] [Related]  

  • 11. Lipid lowering influence of ethyl p-chlorophenoxyisobutyrate in liver of rats fed high fat diets.
    Kokatnur MG; Malcom GT
    Metabolism; 1970 Feb; 19(2):120-8. PubMed ID: 5410942
    [No Abstract]   [Full Text] [Related]  

  • 12. The hypolipidaemic effect of gemfibrozil (CI-719) in laboratory animals.
    Rodney G; Uhlendorf P; Maxwell RE
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):6-10. PubMed ID: 828263
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabolic effects of clofibrate on experimental animals.
    Bedö M; Kramer M; Blaskovits A; Gefferth G; Tarjan R
    Arzneimittelforschung; 1978; 28(7):1076-80. PubMed ID: 582692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of clofibrate on plasma lipid concentration and liver malic enzyme gene expression in rats with experimental chronic renal failure.
    Korczyńska J; Stelmańska E; Nieweglowski T; Szołkiewicz M; Rutkowski B; Swierczyński J
    Pol J Pharmacol; 2000; 52(4):291-7. PubMed ID: 11345485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal models for screening hypolipidemic drugs. III. The response of nicotinic acid and clofibrate in fed and fasted old rats.
    Magnusson O; Andersson I; Nordlund L
    Z Versuchstierkd; 1978; 20(1):46-58. PubMed ID: 636683
    [No Abstract]   [Full Text] [Related]  

  • 16. Newer hypolipidemic agents.
    Kritchevsky D
    Fed Proc; 1971; 30(3):835-40. PubMed ID: 4996475
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluation of the antilipaemic potential of etofylline clofibrate, its metabolites and clofibrate in dietary-induced hyperlipidaemia in the rat (author's transl)].
    Sterner W; Chibanguza G; Metz G
    Arzneimittelforschung; 1980; 30(11b):2038-41. PubMed ID: 7194056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanisms of the antilipemic action of niacin].
    Vinogradov VV; Mandrik KA; Tarasov IuA; Strumilo SA; Matsiuk SK
    Vopr Pitan; 1978; (1):36-40. PubMed ID: 146967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hypolipidemic effect of a new ACAT inhibitor, VULM 1457, in diabetic-hypercholesterolaemic rats.
    Adameová A; Kuzelová M; Faberová V; Svec P
    Pharmazie; 2005 Sep; 60(9):714-5. PubMed ID: 16222877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preliminary study of the tolerance of 3-nicotinoyl-oxypropyl p-chlorophenoxy isobutyrate (I. 612) and on its effects on plasma lipid pattern, hemostasis and clotting-fibrinolysis balance].
    Buzzelli G; Doni A; Lippi G; Resina A
    Clin Ter; 1979 May; 89(3):251-66. PubMed ID: 466976
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.